Drug Trial Radar · NCT00954629
A Study of the Efficacy and Safety of 2PX in Patients With Pain Due to Osteoarthritis of the Knee
Last checked: Nov 19, 2026Latest source record: Mar 24, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
Jun 2009
Primary completion
May 2010
Study completion May 2010
Sponsor
- Lead sponsor
- Smerud Medical Research International ASAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- SantoSolve AS
- First posted
- Aug 7, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to demonstrate the superiority of topically administered 2PX versus placebo (vehicle) control in terms of reduction in pain intensity and physical function.
Conditions
- Pain
- Osteoarthritis
Interventions
strontium chloride hexahydrateDrug
Topical solution to be applied twice daily for 26 weeks. Dosage of up till 4 ml per application.
PlaceboDrug
Topical solution to be applied twice daily for 26 weeks. Dosage up till 4ml per application.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The difference between the active and placebo group in the change from Baseline to the assessment after 26 weeks of treatment in the actual WOMAC Osteoarthritis Index LK 3.1 subscale score for pain and physical function.Time frame: 26 weeks
Locations
15 sites in 4 countries. Site status is shown where the registry gives one.
Site in Helsinki
Helsinki, Finland · Completed
Site at Kuopio
Kuopio, Finland · Completed
Site in Turku
Turku, Finland · Completed
Site in Bialystok
Bialystok, Poland · Completed
Site in Kraków
Krakow, Poland · Completed
Site in Warszawa
Warsaw, Poland · Completed
Site in St-Petersburg
Saint Petersburg, Russia · Completed
Site in St-Petersburg
Saint Petersburg, Russia · Recruiting
Site in Blackpool
Blackpool, United Kingdom · Completed
Site in Bolton
Bolton, United Kingdom · Completed
Site in Bradford
Bradford, United Kingdom · Completed
Site in Manchester
Manchester, United Kingdom · Completed
Site at Cheadle Hulme
Stockport, United Kingdom · Completed
Site at Heald Green
Stockport, United Kingdom · Completed
Site at Heaton Moor
Stockport, United Kingdom · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.